IT | 2010-03-07
Expanded Technology Partnership to Increase Integration of 6WIND’s Multicore Embedded Networking Software with Emerson Network Power’s AdvancedTCA® Platforms
Technology Partnership Expansion Includes Integrating 6WINDGate™ Embedded Networking Software on
OCTEON™-Based Emerson Network Power Platforms; Enhanced Joint Marketing and Sales Efforts
Mountain View, California – Jan. 11, 2010 – 6WIND, the leading provider of high-performance packet processing embedded software for networking and telecommunications equipment, and Emerson Network Power, a business of Emerson and the global leader in enabling Business-Critical Continuity™, today announced an expansion of their technology partnership for joint multicore-based solutions. As part of the expansion, 6WIND will further integrate its 6WINDGate™ embedded networking software for multicore with Emerson Network Power AdvancedTCA® (ATCA®) blades based on Cavium Networks OCTEON™ processors. The first expanded integration of 6WINDGate features Emerson Network Power’s ATCA-9305, an ATCA blade based on dual OCTEON CN5860 processors and the Freescale™ Semiconductor MPC8548 management processor.
The solutions will be supported with newly enhanced sales and marketing efforts by Emerson Network Power and 6WIND, with the objective of providing customers with greater integrated solutions that can help accelerate multicorebased designs.
The ATCA-9305 is targeted at security and packet-processing applications in the wireless and telecommunications transport markets. This market includes data plane packet processing, security co-processing, video compression and pattern matching. The ATCA-9305 complies with the SCOPE recommended profile for central office ATCA systems, CP-TA rules for interoperability with ATCA shelves and the PICMG® 3.0 ATCA specifications.
The ATCA-9305 is designed in the tradition of Emerson Network Power’s ATCA product portfolio. Reliability, high availability and field maintainability are the key means for reducing operational expenses. Capital expense is lowered drastically at the system level by introducing a new class of performance density, based on state-of-the-art multicore packet processing technologies. It will use 6WINDGate embedded networking software to greatly expedite the multicore design of embedded networking functionality and integration of applications running on this multicore-based architecture.
“Our joint solutions are already in use with a variety of tier one customers helping them realize powerful networking solutions with simplified design and development processes,” commented Dick DuBois, senior vice president, embedded Computing & Power, Emerson Network Power. “Our increased collaboration will provide a broader spectrum of joint and tightly integrated solutions in terms of technology, sales and support.”
6WINDGate is 6WIND’s high-performance packet processing embedded software solution for networking and telecommunications equipment. With optimized support for multicore platforms from multiple embedded processor suppliers, 6WINDGate allows system developers to focus their design efforts on their own value-added software components, with 6WINDGate implementing the low-level packet processing and data plane functions. This allows customers to maximize the system-level performance of their platform while enjoying the ability to seamlessly scale from single-core systems to more complex multicore architectures. 6WINDGate provides several key advantages for telecommunications, security and networking equipment manufacturers, as well as for embedded processor suppliers:
• Maximizes the ability to benefit from performance gains offered by multicore processors
• Scales from one to any number of cores using simple-to-implement differing profiles
• Enables seamless integration of the multicore executive environment (MCEE) with any Linux architecture using an open and standards-based approach Emerson and 6WIND Expand Tech Partnership 2-2-2-2
• Off-the-shelf ready with a complete set of networking features expedites networking design times by as
much as 70 percent
• Complete XML-based manageability eases integration of networking, applications and value-added features
• Maximizes customers’ reuse of existing software
• Reduces development cycles and design time leading to cost reductions and creating a strong value proposition for telecommunications, security and networking equipment manufactures, and chipset providers
The ATCA-9305 uses the 6WINDGate SDS profile for highest performance. 6WINDGate provides a complete readyto- use networking solution including dual-IP networking protocols, comprehensive L2/L3 networking functions, unicast and multicast forwarding, virtual routing, tunneling, IPsec via built-in crypto processors, stateful firewall, QoS, NAT, and a VNB framework designed to easily integrate new interfaces such as WiMAX or L2 protocols. 6WINDGate can run as a pure open source or commercial Linux solution (ADS and EDS) or in conjunction with the MCEE (SDS) to provide the highest level of performance and a seamless integration into a customers’ existing Control Plane. It enables an end-to-end simplified design process for all phases, from the ability to develop a system using a simulation environment to the development and integration of applications on multicore chips and the migration of applications to multicore.
“Our joint customers will be able to realize more powerful and design-friendly solutions for a variety of applications,” said Eric Carmès, CEO of 6WIND.” This includes telecommunications infrastructure equipment such as 4G, LTE, and wired applications; enterprise gateways; security appliances; network offload engines for IP-based applications and more. We’re excited about the prospects of partnering with Emerson Network Power to jointly address a myriad of application and design needs around advanced multicore architectures.”
About Emerson Network Power
Emerson Network Power, a business of Emerson, is the global leader in enabling Business-Critical Continuity™ from grid to chip for telecommunication networks, data centers, health care and industrial facilities. Emerson Network Power provides innovative solutions and expertise in areas including AC and DC power and precision cooling systems, embedded computing and power, integrated racks and enclosures, power switching and controls, monitoring, and connectivity. All solutions are supported globally by local Emerson Network Power service technicians. For more information on Emerson Network Power’s embedded computing products and services including ATCA®, COM Express™, CompactPCI®, embedded motherboards, MicroTCA®, VMEbus and OpenSAF® for original equipment manufacturers and systems integrators in the telecommunications, industrial automation, aerospace/defense and medical markets, visit www.EmersonNetworkPower.com/EmbeddedComputing. Learn more about Emerson Network Power products and services at www.EmersonNetworkPower.com.
About 6WIND
6WIND provides high-performance packet processing embedded software solutions used by networking and telecommunications companies providing equipment for converged, all-IP networks. The company’s 6WINDGate™ solution maximizes the packet processing performance of single- and multicore platforms from several processor suppliers, allowing customers to focus on their own value-added software applications and minimize their time-tomarket. To ensure the availability of a complete system-level ecosystem, 6WIND partners with industry-leading suppliers of multicore processors, board-level products, operating systems and embedded software products worldwide. 6WIND is a privately-owned company based near Paris, France with a subsidiary in California, a sales and support office in Asia, and an R&D center in Beijing, China. For more information, visit www.6wind.com. Note: References to company, product, brand, service or similar names may be trademarks owned by their respective company. Business-Critical Continuity and Emerson Network Power are trademarks and service marks of Emerson Electric Co
Life Science | 2010-02-24
Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
OMAHA, Neb. (February 24, 2010) – Transgenomic, Inc. (OTC/BB: TBIO) announced today that it has
licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company’s CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.
“We are pleased to have the opportunity to develop and offer a genetic test to clinicians and parents that
will assist in the evaluation of children who are thought to be at high risk of being autistic,” stated Craig Tuttle, president and chief executive officer of Transgenomic. “We believe that the use of this test in conjunction with standard diagnostic tools will allow for the earlier diagnosis of autism, and importantly, the more timely initiation of treatment plans for these children. We look forward to adding this proprietary test to our growing commercial offerings.”
Autism is a developmental disorder that causes significant social, communication and behavioural challenges in children. The Centers for Disease Control and Prevention estimates that one in 110 children
in the U.S. has an autism-related disorder, and that the incidence of autism is up 57 percent from 2002 to 2006. Even though parents typically express concerns about their child's developmental progress before the age of three, the average age of diagnoses is not until 53 months. Early intervention has been shown to be effective in improving a child’s ability to develop into a competent adult. Children with a sibling who has been diagnosed with autism are at a significantly greater risk of developing the disorder.
“IntegraGen is excited about the opportunity for our technology to be commercialized by Transgenomic,”
said Dr. Bernard Courtieu, chief executive officer of IntegraGen. “We will continue our gene discovery efforts to further our understanding of autism while focusing on other diseases where molecular tests may help with patient diagnosis and disease management.”
About IntegraGen
IntegraGen (www.integragen.com) is a Biotechnology Company dedicated to gene discovery which allows for the development of molecular diagnostics products and services that provide clinicians with new tools to personalize diagnosis, treatment, and therapy. IntegraGen is focused on the prevention and proactive management of complex debilitating diseases, and dedicated to addressing the needs of patients, clinicians, and advocacy groups. IntegraGen’s Genetic Services Business also provides state of the art Genotyping Services to the research community. With discovery and intellectual property focused on Autism, Oncology and Metabolism, IntegraGen’s Core Strategy is to deliver a portfolio of high-value molecular diagnostic products and services that drive personalized healthcare solutions for complex diseases.
About Transgenomic, Inc.
Transgenomic, Inc. (www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE® Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,475 systems have been shipped to customers in more than 30 countries. The SURVEYOR® Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared with manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomics Services is a CRO for pharmacogenomic, translational research and clinical trials.
Forward-Looking Statements
Certain statements in this press release constitute “forward-looking statements” of Transgenomic within
the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management’s current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic’s filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.
IT | 2010-02-03
Entrepreneurs et Investisseurs Technologies annonce l’acquisition de la société Adeon
Paris, le 3 février 2010.
CDC Innovation et Entrepreneurs & Investisseurs Capital, qui ont pour objectif commun, au travers d’Entrepreneurs et Investisseurs Technologies (« EI-Technologies »), de bâtir un groupe de spécialistes à forte valeur ajoutée dans les domaines les plus innovants du conseil et des services en systèmes d’information, annoncent l’acquisition de la société Adeon.
Adeon est une société de conseil spécialisée dans l’amélioration des processus et outils de vente et de marketing. Elle a été fondée en 2003 par Christophe RITTANO qui rejoint le Comité Exécutif de EITechnologies.
Adeon accompagne les directions métiers et la DSI de grands comptes dans toutes les phases critiques de leurs projets CRM, Business Intelligence ou Internet : du cadrage stratégique au déploiement en filiales, en passant par le challenge des besoins métiers, le choix et la mise en oeuvre de solutions ou le pilotage opérationnel du projet et des risques.
L’acquisition d’Adeon s’inscrit dans la stratégie de renforcement du positionnement de spécialiste de EI-Technologies en particulier dans les domaines du CRM et du Cloud Computing. Notre ambition est de viser une position unique de leader innovant et reconnu pour aider nos clients à tirer le profit maximal des ruptures technologiques actuelles avec les offres suivantes :
· Accompagnement des métiers et des processus transverses les plus impactés (Marketing,
Commerce, Achats, SAV, SI, Dématérialisation des processus),
· Définition de la stratégie de Sourcing des directions informatiques,
· Implémentation des innovations les plus récentes et les plus performantes en termes de Cloud
Computing et d’Open Source,
· Accompagnement des changements organisationnels et humains,
· Maintien de la qualité et de la performance des systèmes d’information grâce au Testing,
· Accroissement de la Sécurité.
Avec Adeon, le chiffre d’affaires annuel de EI-Technologies dépasse 20 M€.
A propos de CDC Innovation
Créée en 1996, CDC Innovation (www.cdcinnovation.com) est une société de venture capital basée à Paris. Avec plus de 415 M€ de fonds sous gestion, elle investit dans des entreprises innovantes en phase de premiers développements ou en phase de croissance, dans deux secteurs: les technologies de l'information et les sciences de la vie.
Son objectif est de créer de la valeur en apportant à des entrepreneurs de talent les ressources, l'expérience et le réseau nécessaires pour transformer des sociétés technologiques à haut potentiel en de véritables succès industriels.
A propos de EI-Capital
Créée en 2007 par Bechara RAAD, Jean-Arnaud de LASA et Pierre SARROLA, Entrepreneurs & Investisseurs Capital est une société d’investissement spécialisée dans l’acquisition et le management de PME en transmission. Elle élabore aujourd’hui deux regroupements sectoriels, le premier dans le domaine du conseil et des services en systèmes d’information, le second dans la fourniture de solutions technologiques pour l’immobilier.
IT | 2010-01-25
Fluidigm, IntegraGen form French Alliance
January 25, 2010 By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Fluidigm and IntegraGen today said that the firms have formed an alliance to bring Fluidigm's products to researchers in France.
Evry, France-based IntegraGen will offer services to its customers using Fluidigm's BioMark System for genetic analysis and Access Array sample preparation system for next-generation sequencing applications. In addition, IntegraGen will serve as a demonstration site for Fluidigm's technology.
"These tools complete the IntegraGen Services portfolio and put our lab at the cutting edge of genotyping and next generation sequencing capabilities," Emmanuel Martin, director of genomic services at IntegraGen, said in a statement.
Further details of the alliance were not disclosed.
IT | 2010-01-06
STMicroelectronics Pushes the Multi-Touch Screen Market and Unveils Resistive Multi-Touch Single-Chip Controller with Unrivaled Performance
Geneva, January 06 ,2010 - As the latest high-tech devices such as smartphones, mobile internet devices and netbooks adopt multi-touch touchscreens to support increasingly sophisticated ‘apps’ and games, STMicroelectronics (NYSE: STM), a world leader in microcontrollers, has introduced a very advanced multi-touch ‘resistive’ touchscreen controller chip to optimize the Bill of Materials of the electronics supporting this advanced capability. The STM32TS60 is the first member of ST’s new STMTouch family, which offers a broad portfolio of solutions including multi-touch devices and proximity and touch-key sensors.
The new multi-touch controller detects up to ten simultaneous touches with fingers, nails or stylus, enabling application designers to replace complex menu sequences with more direct and natural user controls. Actions made easier with multi-touch capabilities include browsing and selecting options, handwriting and data entry, arranging and sizing windows, picking up and dragging images, and fast and intuitive game play. Other abilities include drawing pictures, using touch pressure to adjust line thickness.
Employing resistive touch-panel technology, the STM32TS60 controller offers customers a real alternative and complements the recent industry trend for using capacitive touch technology. Resistive technology is a cost effective and mature high-volume solution that has seen dramatically improved performance over the past few years in terms of durability and display transparency. In addition, it easily overcomes EMI (electromagnetic interference) noise issues, which can be an inherent limitation with alternative touch technologies. Resistive technology is already widely used in PDAs and similar touch-enabled devices and the screens are readily available in standard LCD sizes and at competitive prices.
The new chip combines the company’s highly efficient STM32 microcontroller architecture with PMatrixTM Multi-Touch technology from ST‘s partner Stantum, a leader in touch-sensing processing, to achieve fast response times while minimizing system complexity and component count.
The STM32TS60 single-core microcontroller is an added-value solution compared to other expensive multi-core processor or digital signal processors (DSPs) requiring specialized programming expertise.
“The STM32T60 is the first member of ST’s new STMTouch family and provides a very low power, highly reliable alternative to capacitive touchscreen solutions,” said Jim Nicholas, General Manager of ST’s Microcontrollers Division. “By leveraging the advanced processing and low power of the STM32 and STM8 processor platforms, and supporting different touchscreen capabilities, STMTouch is a versatile platform for next-generation consumer devices offering compelling features, increased flexibility and more fun for users.”
The STM32TS60’s high EMI immunity makes it suitable for use in multi-function wireless products such as cellphones, notebook PCs, netbooks and mobile Internet devices. Moreover, its low power consumption helps to maximize operating times and recharge intervals, and is a direct benefit of the STM32’s energy-saving design features and ARM® Cortex™-M3 processor conceived for power-sensitive embedded applications. In addition, very-low-power idle mode with ‘wake-up on touch only’ helps further extend mobile battery life.
The STM32TS60 is housed in a 7 x 7mm 144-pin UFBGA package, and is now sampling to lead customers. Volume production is expected for Q2 2010.
STMicroelectronics is a global leader serving customers across the spectrum of electronics applications with innovative semiconductor solutions. ST aims to be the undisputed leader in multimedia convergence and power applications leveraging its vast array of technologies, design expertise and combination of intellectual property portfolio, strategic partnerships and manufacturing strength. In 2008, the Company's net revenues were $9.84 billion. Further information on ST can be found at www.st.com.
